Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA patients. Targeting the root cause, we developed a new self-complementary adeno-associated virus 9 (scAAV9) vector to deliver the human N-sulfoglucosamine sulfohydrolase (hSGSH) gene driven by a miniature cytome...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobo, Tierra A., Samowitz, Preston N., Robinson, Michael I., Fu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704409/
https://www.ncbi.nlm.nih.gov/pubmed/33313335
http://dx.doi.org/10.1016/j.omtm.2020.10.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704409/
https://www.ncbi.nlm.nih.gov/pubmed/33313335
http://dx.doi.org/10.1016/j.omtm.2020.10.014

Ejemplares similares